{
    "2019-12-16": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Lilly board hikes dividend by 15%",
                "features": {
                    "keywords": [
                        "Lilly",
                        "dividend",
                        "hikes",
                        "15%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-20",
                "original_text": "Lilly Announces 15 Percent Dividend Increase",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Announces",
                        "Dividend",
                        "Increase",
                        "15%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-05-10",
                "original_text": "Lilly's Cyramza Gets CHMP Recommendation for First-Line NSCLC",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Cyramza",
                        "CHMP",
                        "Recommendation",
                        "First-Line",
                        "NSCLC"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "oncology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-06-25",
                "original_text": "Lilly to Integrate Dexcom CGM into Personalized Diabetes Management System",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Dexcom",
                        "CGM",
                        "Personalized",
                        "Diabetes",
                        "Management",
                        "System"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "diabetes"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}